ADMA Biologics, Inc. (ADMA)

NASDAQ: ADMA · Real-Time Price · USD

15.68

+0.16 (1.03%)

At close: Feb 25, 2026, 4:00 PM EST

15.79

+0.11 (0.69%)

After-hours: Feb 25, 2026, 7:42 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
ADMA Biomanufacturing	415.81M	249.74M	144.07M	74.94M	36.67M
ADMA Biomanufacturing Growth	66.50%	73.34%	92.26%	104.33%	65.37%
Plasma Collection Centers	10.51M	8.33M	9.87M	5.86M	5.40M
Plasma Collection Centers Growth	26.05%	-15.54%	68.26%	8.52%	-23.13%
Corporate	-	-	-	143.00K	142.83K
Corporate Growth	-	-	-	0.12%	0%
Unallocated License Revenue	143.00K	143.00K	143.00K	-	-
Unallocated License Revenue Growth	0%	0%	-	-	-
Total	426.45M	258.22M	154.08M	80.94M	42.22M
Total Growth	65.15%	67.59%	90.36%	91.72%	43.85%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	410.15M	244.88M	146.43M	70.63M	36.55M
United States Growth	67.49%	67.24%	107.33%	93.22%	24.54%
International	16.31M	13.33M	7.65M	10.32M	5.67M
International Growth	22.29%	74.23%	-25.82%	82.04%	-
Total	426.45M	258.22M	154.08M	80.94M	42.22M
Total Growth	65.15%	67.59%	90.36%	91.72%	43.85%

Source: S&P Global Market Intelligence.